NTRA
Price
$156.93
Change
-$2.88 (-1.80%)
Updated
Aug 13, 03:09 PM (EDT)
Capitalization
21.93B
84 days until earnings call
VYGR
Price
$3.69
Change
+$0.29 (+8.55%)
Updated
Aug 13, 03:09 PM (EDT)
Capitalization
188.04M
97 days until earnings call
Interact to see
Advertisement

NTRA vs VYGR

Header iconNTRA vs VYGR Comparison
Open Charts NTRA vs VYGRBanner chart's image
Natera
Price$156.93
Change-$2.88 (-1.80%)
Volume$300
Capitalization21.93B
Voyager Therapeutics
Price$3.69
Change+$0.29 (+8.55%)
Volume$1.25K
Capitalization188.04M
NTRA vs VYGR Comparison Chart in %
Loading...
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), IQVIA Holdings (NYSE:IQV), Biogen (NASDAQ:BIIB), Incyte Corp (NASDAQ:INCY), Illumina (NASDAQ:ILMN), Exelixis (NASDAQ:EXEL), Moderna (NASDAQ:MRNA), Exact Sciences Corp (NASDAQ:EXAS).

Industry description

Few industries pique investor interest like the high-risk, high-reward biotechnology sector. It is not unusual for a biotech company’s stock to soar in value following the development of a successful product...even if it is just as likely that tens of millions of dollars in research will lead to nothing substantial. Biotech companies earn headlines for developing lifesaving and (potentially) massively lucrative treatments for illness, but the industry’s scope extends beyond healthcare to food and agriculture, industrial processing, and more. Any company producing technology that incorporates biological organisms falls within the sector. The search for the next big thing in biotech may come with risk, but investors have reason for optimism. Biotech products like DNA sequencing and gene therapy are experiencing increased demand and decreasing prices, while rising populations around the world mean demand for food and agricultural products resistant to environmental factors. Biotech’s biggest names include multinational corporations like Johnson & Johnson, Amgen, and Roche, who each sport market capitalizations in the hundreds of billions of dollars. With new government rules opening China as a market for new treatments, the biotech sector holds significant growth potential – and corresponding profitability for investors.

Market Cap

The average market capitalization across the biotechnology Theme is 6.67B. The market cap for tickers in the group ranges from 658 to 180.28B. TMO holds the highest valuation in this group at 180.28B. The lowest valued company is MTEM at 658.

High and low price notable news

The average weekly price growth across all stocks in the biotechnology Theme was 5%. For the same Theme, the average monthly price growth was 6%, and the average quarterly price growth was 27%. BTAI experienced the highest price growth at 129%, while NCNA experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the biotechnology Theme was -10%. For the same stocks of the Theme, the average monthly volume growth was 132% and the average quarterly volume growth was 144%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 77
Price Growth Rating: 58
SMR Rating: 88
Profit Risk Rating: 90
Seasonality Score: -21 (-100 ... +100)

Market Cap

The average market capitalization across the group is 11.06B. The market cap for tickers in the group ranges from 188.04M to 21.93B. NTRA holds the highest valuation in this group at 21.93B. The lowest valued company is VYGR at 188.04M.

High and low price notable news

The average weekly price growth across all stocks in the group was 7%. For the same group, the average monthly price growth was -2%, and the average quarterly price growth was -14%. NTRA experienced the highest price growth at 14%, while VYGR experienced the biggest fall at 0%.

Volume

The average weekly volume growth across all stocks in the group was -27%. For the same stocks of the group, the average monthly volume growth was 81% and the average quarterly volume growth was 79%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 55
Price Growth Rating: 69
SMR Rating: 95
Profit Risk Rating: 69
Seasonality Score: -6 (-100 ... +100)
VS
NTRA vs. VYGR commentary
Aug 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTRA is a Hold and VYGR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 13, 2025
Stock price -- (NTRA: $159.81 vs. VYGR: $3.39)
Brand notoriety: NTRA and VYGR are both not notable
NTRA represents the Medical Specialties, while VYGR is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTRA: 130% vs. VYGR: 114%
Market capitalization -- NTRA: $21.93B vs. VYGR: $188.04M
NTRA [@Medical Specialties] is valued at $21.93B. VYGR’s [@Biotechnology] market capitalization is $188.04M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $96.01B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.21B. The average market capitalization across the [@Biotechnology] industry is $1.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTRA’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • NTRA’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than NTRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTRA’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 7 bullish TA indicator(s).

  • NTRA’s TA Score: 4 bullish, 6 bearish.
  • VYGR’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than NTRA.

Price Growth

NTRA (@Medical Specialties) experienced а +14.05% price change this week, while VYGR (@Biotechnology) price change was +0.30% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.10%. For the same industry, the average monthly price growth was +2.16%, and the average quarterly price growth was -0.57%.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.24%. For the same industry, the average monthly price growth was +20.10%, and the average quarterly price growth was +19.98%.

Reported Earning Dates

NTRA is expected to report earnings on Nov 05, 2025.

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Medical Specialties (+2.10% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Biotechnology (+11.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTRA($21.9B) has a higher market cap than VYGR($188M). NTRA YTD gains are higher at: 0.954 vs. VYGR (-40.212). VYGR has higher annual earnings (EBITDA): -97.25M vs. NTRA (-147.62M). NTRA has more cash in the bank: 992M vs. VYGR (236M). VYGR has less debt than NTRA: VYGR (42M) vs NTRA (196M). NTRA has higher revenues than VYGR: NTRA (1.83B) vs VYGR (67M).
NTRAVYGRNTRA / VYGR
Capitalization21.9B188M11,649%
EBITDA-147.62M-97.25M152%
Gain YTD0.954-40.212-2%
P/E RatioN/A6.00-
Revenue1.83B67M2,733%
Total Cash992M236M420%
Total Debt196M42M467%
FUNDAMENTALS RATINGS
NTRA vs VYGR: Fundamental Ratings
NTRA
VYGR
OUTLOOK RATING
1..100
1074
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
32
Undervalued
PROFIT vs RISK RATING
1..100
39100
SMR RATING
1..100
9596
PRICE GROWTH RATING
1..100
5386
P/E GROWTH RATING
1..100
10010
SEASONALITY SCORE
1..100
3750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (32) in the Biotechnology industry is in the same range as NTRA (61). This means that VYGR’s stock grew similarly to NTRA’s over the last 12 months.

NTRA's Profit vs Risk Rating (39) in the Biotechnology industry is somewhat better than the same rating for VYGR (100). This means that NTRA’s stock grew somewhat faster than VYGR’s over the last 12 months.

NTRA's SMR Rating (95) in the Biotechnology industry is in the same range as VYGR (96). This means that NTRA’s stock grew similarly to VYGR’s over the last 12 months.

NTRA's Price Growth Rating (53) in the Biotechnology industry is somewhat better than the same rating for VYGR (86). This means that NTRA’s stock grew somewhat faster than VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (10) in the Biotechnology industry is significantly better than the same rating for NTRA (100). This means that VYGR’s stock grew significantly faster than NTRA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NTRAVYGR
RSI
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
80%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
NTRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CGMM27.720.66
+2.44%
Capital Group U.S. Small & Mid Cap ETF
IPAC72.391.12
+1.57%
iShares Core MSCI Pacific ETF
RAFE38.800.46
+1.21%
PIMCO RAFI ESG US ETF
XHYE38.560.12
+0.30%
BondBloxx US High Yield Energy Sctr ETF
PHB18.470.05
+0.27%
Invesco Fundamental Hi Yld® Corp Bd ETF

NTRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with ISRG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTRA
1D Price
Change %
NTRA100%
+1.76%
ISRG - NTRA
53%
Loosely correlated
+1.34%
VCYT - NTRA
52%
Loosely correlated
+2.79%
GH - NTRA
50%
Loosely correlated
+0.55%
GKOS - NTRA
47%
Loosely correlated
+2.67%
SMTI - NTRA
45%
Loosely correlated
+2.27%
More

VYGR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+10.06%
RGNX - VYGR
50%
Loosely correlated
+8.58%
KYMR - VYGR
49%
Loosely correlated
+5.81%
XNCR - VYGR
49%
Loosely correlated
+10.71%
XENE - VYGR
47%
Loosely correlated
+5.51%
IMNM - VYGR
46%
Loosely correlated
+2.59%
More